Lawsuits against Juul echo opioid cases
New York and California have sued the e-cigarette company for deceptive marketing that contributed to a public health crisis.
Regulatory
It’s back! Bill requiring list prices in DTC ads resurfaces
Sens. Chuck Grassley and Dick Durbin hoped to pass the bill through unanimous consent last week, ahead of impeachment proceedings and a budget battle.
It’s time to push back on drug price legislation
Sander Flaum wants pharma to push back on pricing legislation.
Patterns emerge as vaping-related lung illnesses continue to rise
As more patients fall ill from the vaping lung illness, health officials are piecing together a more complete picture of the outbreak.
GOP, Dems agree on international reference price policy, but the devil is in the details
International reference pricing for drugs is great in theory, but Dems and the GOP are at odds over the details in each plan.
Report: Stephen Hahn to be nominated as FDA head, Brett Giroir as acting chief
Dr. Stephen Hahn emerged as the frontrunner to lead the FDA in recent months.
FDA’s first ‘modified risk’ tobacco products set precedent
They could set the standard for vaping products.
Timeline: Pharma navigates the first federal opioid trial
The case brought by two Ohio counties was set to be a bellwether for the remaining federal lawsuits.
Last-minute settlements delay Ohio opioid trial
Three drug distributors and a pharma company reached deals to avoid going to trial Monday.
Healthcare moments from Tuesday’s Democratic debate
Healthcare-related topics included tax increases under Medicare For All and holding pharma accountable for the opioid epidemic.
Want to read more?
Please login or register first to view this content.
